About APIcells
APIcells is a company based in Lowell (United States) founded in 2013. It operates as a B2B, and Distribution Partnership. APIcells offers products and services including Cell Pellets, Nuclear Extracts, and Cytoplasm Extracts. APIcells operates in a competitive market with competitors including 10X Genomics, MaxCyte, Mission Bio, SQZBiotech and Cellares, among others.
- Headquarter Lowell, United States
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Latest Funding Round
-
Investors
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of APIcells
APIcells offers a comprehensive portfolio of products and services, including Cell Pellets, Nuclear Extracts, and Cytoplasm Extracts. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Products for research involving mammalian cell cultivation and analysis
Derivatives from Hela cell lines for molecular biology studies
Materials for cellular research and protein extraction purposes
Funding Insights of APIcells
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investments & Acquisitions by APIcells
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - APIcells
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Apicells Comparisons
Competitors of APIcells
APIcells operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as 10X Genomics, MaxCyte, Mission Bio, SQZBiotech and Cellares, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Instrument systems for genomic research and sequencing libraries are developed.
|
|
| domain | founded_year | HQ Location |
Instrument systems for cell processing and modification are provided.
|
|
| domain | founded_year | HQ Location |
Single-cell multi-omics platform is provided for genotypic and phenotypic analysis.
|
|
| domain | founded_year | HQ Location |
Cell therapies are developed using proprietary Cell Squeeze technology.
|
|
| domain | founded_year | HQ Location |
Medical devices for cell-based therapy manufacturing are produced.
|
|
| domain | founded_year | HQ Location |
Optical tweezers instruments for single-molecule analysis are manufactured.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Frequently Asked Questions about APIcells
When was APIcells founded?
APIcells was founded in 2013.
Where is APIcells located?
APIcells is headquartered in Lowell, United States. It is registered at Lowell, Massachusetts, United States.
What does APIcells do?
Apicell focuses on the production and exploitation of mammalian cells, offering products like cell pellets, nuclear extracts, and cytoplasm extracts. The company operates by maintaining stock for immediate shipping and collaborates with partners for North American distribution. Based in Lowell, MA, USA, it serves academics, public, and private research entities with high-quality biologicals derived from Hela cell lines, emphasizing cost-effective and rapid delivery solutions.
Who are the top competitors of APIcells?
APIcells's top competitors include MaxCyte, 10X Genomics and Mission Bio.
What products or services does APIcells offer?
APIcells offers Cell Pellets, Nuclear Extracts, and Cytoplasm Extracts.